drugset / Trial / NCT04170270

Oral Omeprazole in Bleeding Peptic Ulcer

NCT04170270

Phase 0 Unknown 100 enrolled Assiut University
RandomizedParallel-groupSingle-blindTreatment

Summary

Find out if there is a significant difference between clinical outcome among the patients with bleeding peptic ulcer treated with oral omeprazole compared to those treated with intravenous omeprazole.

Timeline

Start
2019-11
Primary completion
2020-12
Completion
2021-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Omeprazole Other / unclassified 8 mg Oral
Subject Omeprazole Other / unclassified 40 mg Oral